<?xml version="1.0" encoding="UTF-8"?>
<ref id="B54">
 <mixed-citation publication-type="other">
  <person-group person-group-type="author">
   <name>
    <surname>Kewan</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Covut</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Al–Jaghbeer</surname>
    <given-names>M. J.</given-names>
   </name>
   <name>
    <surname>Rose</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Gopalakrishna</surname>
    <given-names>K. V.</given-names>
   </name>
   <name>
    <surname>Akbik</surname>
    <given-names>B.</given-names>
   </name>
  </person-group> (
  <year>2020</year>). 
  <article-title>Tocilizumab for treatment of patients with severe COVID–19: A retrospective cohort study</article-title>. 
  <source>E. Clin. Med.</source>, 
  <elocation-id>100418</elocation-id>. 
  <pub-id pub-id-type="doi">10.1016/j.eclinm.2020.100418</pub-id>
 </mixed-citation>
</ref>
